Download PDF PDX Core PDX List (Pediatric & Adolescent) library
| Rhabdomyosarcoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 1 | PDX | Rh10 | ARMS | 15 | Female | White | Liver | Relapse |
| 2 | PDX | Rh28 | ARMS | 17 | Male | White | Hand | Diagnosis |
| 3 | PDX | Rh30 | ARMS | 16 | Male | White | Bone Marrow | Diagnosis |
| 4 | PDX | Rh30R | ARMS | 16 | Male | White | Bone Marrow | Relapse |
| 5 | PDX | Rh41 | ARMS | 12 | Female | White | Unknown | Autopsy |
| 6 | PDX | Rh65 | ARMS | 18.5 | Female | White | Unknown | Relapse |
| 7 | PDX | Rh18 | ERMS | 2 | Female | White | Perineum | Diagnosis |
| 8 | PDX | Rh36 | ERMS | 15 | Male | White | Paratesticular | Relapse |
| 9 | PDX | Rh-66 | ARMS (not SJ sample) | 12.5 | Female | Not recorded | Axillary lymph node | Metastasis |
| 10 | PDX | Rh-12 | ERMS | 12 | Male | Not recorded | Right Buttock | Diagnosis |
| 11 | PDX | Rh-14 | ERMS | 14 | Male | Buttock | Diagnosis | |
| 12 | PDX | NCH-ERMS-1 | ERMS | 5 | Male | Not recorded | orbital | No treatment |
| 13 | PDX | NCH-ARMS-2 | ARMS metastatic | 16 | Female | Not recorded | Right breast | Treated |
| 14 | PDX | UTSW-054 | ERMS | 10 | Male | White/Hispanic | Parotid | Treated |
| 15 | PDX | Rh70 | ERMS | 4 | Male | African-American | Right neck mass | No treatment |
| 16 | PDX | Rh71 | ERMS high grade | 17 | Male | White | Prostate | Diagnosis |
| 17 | PDX | Rh72 | ERMS | 3 | Female | White | Perineal | Treated |
| 18 | PDX | Rh73 | ERMS | 5 | Male | White | Right Infratemporal fossa mass | Treated |
| 19 | PDX | Rh75 | ERMS | 17 | Male | White | Pelvis recurrent (Rh71) | Treated |
| 20 | PDX | Rh76 | ERMS anaplastic | 15 | Female | White | Left eye | Treated |
| 21 | PDX | Rh78 | ARMS | 1y 1m | Male | Not recorded | Right thigh | No treatment |
| 22 | PDX | Rh80 | ERMS anaplastic | 5 | Female | White | Stomach mass | Treated |
| 23 | PDX | Rh81 | ERMS | 9 | Male | Biracial | Abdominal mass | Treated |
| 24 | PDX | Rh82 | ARMS | 3 | Male | Not recorded | Paratesticular | Treated |
| 25 | PDX | Rh83 | ERMS | 4 | Male | Not recorded | Left orbital mass | Treated |
| 26 | PDX | Rh84 | ARMS | 2 | Male | Not recorded | Upper lip lesion | Treated |
| 27 | PDX | Rh85 | ERMS with diffuse anaplasia | 5 | Female | Not recorded | Abdominal mass | No treatment |
| 28 | PDX | Rh86 | ERMS | 8 | Male | Not recorded | Retroperitoneal mass | Treated |
| 29 | PDX | Rh87 | ERMS spindle cell/ sclerosing | 6 | Female | Not recorded | Oropharyngeal mass | Treated |
| 30 | PDX | Rh88 | ERMS | 10 | Male | Not recorded | Pelvic mass | Treated (autopsy) |
| 31 | PDX | IRS-56 | ERMS | 3 | Male | Not recorded | Buttock | Diagnosis |
| 32 | PDX | IRS-68 | ERMS | 13 | Male | Not recorded | Shoulder | Diagnosis |
| 33 | PDX | SJRHB011_X | ERMS | 5 | Male | Not recorded | Infratemporal fossa | Recurrent |
| 34 | PDX | SJRHB013_X | ERMS | 3 | Female | Not recorded | Perineal/bladder | Recurrent |
| 35 | PDX | SJRHB010927_X1 | ERMS | 5 | Female | Not recorded | Parapharyngeal | Diagnosis |
| 36 | PDX | SJRHB000026-X | ERMS | 4 | Female | Not recorded | Pelvis | Recurrent |
| 37 | PDX | SJRHB013758_X1 | ERMS | 4 | Female | Not recorded | Abdomen/pelvis | Diagnosis |
| 38 | PDX | SJRHB013758_X2 | ERMS | 5 | Female | Not recorded | Abdomen/pelvis | Recurrent |
| 39 | cell line | SMS-CTR # | ERMS | 1 | Male | Not recorded | Pelvis | Diagnosis |
| 40 | cell line | RD # | ERMS | 7 | Female | Not recorded | Pelvis | Relapse |
| 41 | cell line | Rh10 # | ARMS | 15 | Female | White | Liver | Relapse |
| 42 | cell line | Rh18 # | ERMS | 2 | Female | White | Perineum | Diagnosis |
| 43 | cell line | Rh28/LPAM # | ARMS | 17 | Male | White | Hand | Diagnosis |
| 44 | cell line | Rh36 # | ERMS | 15 | Male | White | Paratesticular | Relapse |
| 45 | cell line | Rh41 # | ARMS | 12 | Female | White | Perineum | Autopsy |
| Ewing Sarcoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 46 | PDX | Adamantinoma-like Ewing sarcoma, ALES | Metastasis | 25 yo | Female | Treated | ||
| 47 | PDX | EW-5 | Primary | 16y 9m | Male | White | Paraspinal | Relapse |
| 48 | PDX | EW-9 | Metastasis | 16 | Female | African-American | Lung metastasis | No treatment |
| 49 | PDX | EW-10 | Primary | 11 | Female | White | Right thigh mass | No treatment |
| 50 | PDX | EW-12 | Primary | 13 | Male | Not recorded | Left foot mass | No treatment |
| 51 | PDX | EW-13 | Primary | 10 | Male | Not recorded | Right proximal tibia | No treatment |
| 52 | PDX | EW-14 | Metastasis | 11 | Female | Not recorded | Left lung mass | Treated |
| 53 | PDX | NCH-EWS1 | Metastatic | 15 | Male | Not recorded | Lung | Recurrent |
| 54 | PDX | UTSW-2197 | Primary | 11 | Male | Hispanic/White | Right tibia | Treated |
| 55 | PDX | UTH-0584-000 | Suspected Ewing sarcoma | Posterior chest wall tumor | ||||
| 56 | PDX | UTH-0589-000 | Suspected Ewing sarcoma | |||||
| 57 | CDX/cell line | ES-1 # | Primary | 45 | Female | Not recorded | Left thigh | Diagnosis |
| 58 | CDX/cell line | ES-2 # | Metastasis | 14 | Female | Not recorded | Ileum/Bone marrow | Relapse/BMA |
| 59 | CDX/cell line | ES-3 # | Primary | 12 | Male | Not recorded | Pubis/Bone marrow | Relapse |
| 60 | CDX/cell line | ES-4 # | Primary | 18 | Male | Not recorded | 8th Rib | Relapse |
| 61 | CDX/cell line | ES-6 # | Primary | 17 | Male | Not recorded | Right proximal tibia | Relapse |
| 62 | CDX/cell line | ES-7 # | Neither | 15 | Male | Not recorded | Right fibula/bone marrow | Relapse (3d surgery) |
| 63 | CDX/cell line | ES-8 # | Primary | 10 | Male | Not recorded | Left proximal humerus/Bone marrow | Relapse (24 days post Dx) |
| 64 | CDX/cell line | TC-71 # | Primary | 22 | Male | Not recorded | Humerus | Relapse |
| 65 | CDX/cell line | CHLA-258 # | Primary | 14 | Female | Hispanic/Latino | Lung | Relapse |
| 66 | CDX/cell line | SK-NEP-1 # | Primary, Metastasis | 25 | Female | White | Pleural effusion | Treated |
| 67 | CDX/cell line | CHLA-9 # | Primary | 14 | Female | White | Thoracic mass | Diagnosis |
| 68 | CDX/cell line | CHLA-10 # | Lymph node | 14 | Female | White | Thoracic lymph node | Relapse |
| 69 | CDX/cell line | EW-8 # | Primary | 17y 9m | Male | White | Abdominal mass | No treatment (originally Dx as ERMS) |
| Rhabdoid Tumor (non-CNS) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 70 | PDX | KT-12 | Rhabdoid Secondary | 6m | Male | White | Ventricular Mass | Diagnosis |
| 71 | PDX | KT-14 | Rhabdoid Primary | 16y 10m | Female | Not recorded | Kidney | Relapse |
| 72 | PDX | NCH-RBD-1 | Metastasis | 1 | Female | Not recorded | Lung | Diagnosis |
| 73 | PDX | NCH-RBD-2 | Metastasis | 9 | Female | White | Liver | Diagnosis |
| 74 | CDX/cell line | G401 * | Rhabdoid | 3m | Male | White | Kidney | Diagnosis |
| 75 | CDX/cell line | MP-MRT-AN * | Rhabdoid | 3m | Female | Asian | Liver | Diagnosis |
| 76 | CDX/cell line | KP-MRT-RY * | Rhabdoid | 1m | Male | Asian | L. Kidney | Diagnosis |
| 77 | CDX/cell line | KP-MRT-NS * | Rhabdoid | 2m | Female | Asian | Ascitic fluid | Treated |
| 78 | CDX/cell line | KP-MRT-YM * | Rhabdoid | 5m | Male | Asian | Chest wall | Diagnosis |
| Wilm’s Tumor | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age,years old | Gender | Race | Site | Diagnosis or Relapse |
| 79 | PDX | KT-5 | Secondary | 6 | Male | White | Kidney | Diagnosis |
| 80 | PDX | WT-6 (KT-6) | Primary | Unknown | Male | Not recorded | Kidney | Diagnosis |
| 81 | PDX | WT-8 (KT-8) | Primary | Unknown | Unknown | Unknown | Left kidney | Diagnosis |
| 82 | PDX | KT-10 | Primary | 6y 9m | Male | African-American | Kidney | Diagnosis |
| 83 | PDX | KT-11 | Primary | 4y10m | Female | African-American | Kidney | Diagnosis |
| 84 | PDX | KT-13 | Primary | 3 | Female | White | Right kidney + ureter | Diagnosis |
| 85 | PDX | KT-16 | Secondary | 10m | Female | Pacific Islander | Kidney | Relapse |
| 86 | PDX | NCH-WT-3 (KT-3) | Diffuse anaplasia | 3 | Male | Not recorded | Right kidney | Diagnosis |
| 87 | PDX | NCH-WT-4 (KT-4) | Primary | 4 | Male | Not recorded | Left kidney | Recurrent |
| 88 | PDX | NCH-WT-5 (KT-5) | Primary triphastic | 5 | Female | Not recorded | Left kidney | Diagnosis |
| 89 | PDX | NCH-WT-6 (KT-6) | Primary triphastic | 1 | Female | Not recorded | Left kidney | Diagnosis |
| 90 | PDX | NCH-WT-7 | Metastatic | 5 | Male | Not recorded | Lung | Recurrent |
| 91 | PDX | NCH-WT-8 | Primary | 2 | Female | Not recorded | Right kidney | Recurrent |
| 92 | PDX | NCH-WT-9 | Primary anaplasia | 1 | Female | Not recorded | Left Kidney | Diagnosis |
| 93 | PDX | UTH-0561-000 | Recurrent progressive | 18 | Female | Non-Hispanic / White | Right upper quadrant kidney | Chemotherapy |
| 94 | PDX | UTSW-0668. FT1366 | Primary | 4 | Male | Hispanic / White | Left Kidney | No treatment |
| 95 | PDX | UTSW-0655. FT1332 | Metastasis | 5 | Male | Non-Hispanic / African American | Left Kidney | No treatment |
| 96 | PDX | UTH-0560. FT 1062 | Primary | 17m | Female | Non-Hispanic / White | Right Kidney | No treatment |
| 97 | PDX | UTSW-2264 | Retroperitoneal metastasis | 6 | Male | Non-Hispanic / White | Liver | S/p Chemotherapy |
| 98 | PDX | UTSW-2083 | Primary | 7 | Female | Non-Hispanic / African American | Left Kidney | No treatment |
| 99 | PDX | UTSW-2050 | Primary | 2 | Female | Hispanic / White | Right Kidney | No treatment |
| 100 | PDX | UTSW-1960 | Primary | 9 | Female | Non-Hispanic / African American | Left Kidney | No treatment |
| 101 | PDX | UTSW-1823 | Primary | 5 | Female | Non-Hispanic / White | Right Kidney | No treatment |
| 102 | PDX | UTSW-1763 | Primary | 4 | Female | Non-Hispanic / African American | Right Kidney | No treatment |
| 103 | PDX | UTSW-1753 | Primary (Anaplasia, Metastasis to liver) | 11 | Male | Non-Hispanic / African American | Pelvis | No treatment |
| 104 | PDX | UTSW-1912 | Primary | 3 | Female | Hispanic/White | Right Kidney | No treatment |
| 105 | PDX | UTSW 0753.FT1554 | Non-Hispanic / White | |||||
| 106 | PDX | UTSW 1932 | Non-Hispanic / White | |||||
| 107 | PDX | UTSW 0762.FT1562 | Non-Hispanic / White | |||||
| 108 | PDX | UTSW 0777.FT1594 | Hispanic / White | |||||
| 109 | PDX | 0859.FT1716 | Non-Hispanic / White | |||||
| 110 | PDX | COG 907244 | Not available |
| Hepatoblastoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 111 | PDX | UTSW-1925 | Primary | 3 | Female | Hispanic/White | Liver | Chemotherapy |
| 112 | PDX | UTSW-2237.FT2342 | Primary | 10m | Female | African-American | Liver | No treatment |
| 113 | PDX | UTSW-1739 | Primary | 3 | Male | Non-Hispanic/White | Liver | Chemotherapy |
| 114 | PDX | UTSW-0585.FT1232 | Primary | 2 | Male | Hispanic/White | Liver | Chemotherapy |
| 115 | PDX | COG-896868 | Primary | 13m | Female | Non-Hispanic/White | Liver | No treatment |
| 116 | PDX | UTSW-1957 | Metastatic | 16m | Male | Hispanic/White | Liver | Chemotherapy |
| 117 | PDX | UTSW-0498.FT0921 | Primary | 18m | Female | Hispanic/White | Liver | No treatment |
| 118 | PDX | UTSW-0707.FT1484 | Primary | 4m | Female | Hispanic/White | Liver | No treatment |
| 119 | PDX | UTSW 1739 | Primary | Non-Hispanic / White | ||||
| 120 | PDX | UTH 0494-000 | Primary | Non-Hispanic / White | ||||
| 121 | PDX | UTSW 1925 | Primary | Hispanic / White | ||||
| 122 | PDX | UTH 0511-000 | Primary | Non-Hispanic / White | ||||
| 123 | PDX | UTSW 1959 | Primary | Hispanic / White | ||||
| 124 | PDX | UTH 0543-000 | Primary | Middle Eastern | ||||
| 125 | PDX | COG 891173 | Primary | Non-Hispanic / Asian | ||||
| 126 | PDX | COG 891760 | Primary | Hispanic / White | ||||
| 127 | PDX | COG 896492 | Liver tumor, diagnosis pending | Not available | ||||
| 128 | PDX | COG # 896868 | Primary | Non-Hispanic / White | ||||
| 129 | PDX | UTSW 0585.FT1232 | Primary | Hispanic / White | ||||
| 130 | PDX | COG 901402 | Primary | Not available | ||||
| 131 | PDX | COG940474 | Primary, Specimen time point: diagnosis | 3 | Primary site - liver | NO any treatment prior to date specimen was collected | ||
| 132 | PDX | UTH 0648-000 | Primary | Non-Hispanic / White | ||||
| Hepatoblastoma (Other) | ||||||||
| 133 | PDX | UTH-0494 | Primary | 12y 8m | Male | Hispanic/White | Liver | No treatment |
| 134 | PDX | UTSW-1959 | Primary, mixed epithelial & stromal | 2 | Male | Hispanic/White | Liver | No treatment |
| 135 | PDX | UTH-0511 | Primary | 13y 8m | Male | Hispanic/White | Liver | No treatment |
| 136 | PDX | COG-891173 | Primary | 21m | Female | Asian | Liver | Diagnosis |
| 137 | PDX | COG-891760 | Primary | 5m | Male | Hispanic/White | Liver | Diagnosis |
| 138 | PDX | NCH-HEP1 | Primary | 11m | Male | Not recorded | Liver | Diagnosis |
| 139 | PDX | UTH-0543-000 | Primary | 1y 5m | Female | Middle Eastern | Liver | No treatment |
| 140 | PDX | COG896492 @ | Primary |
| Brain Tumor (CNS, Medulloblastoma) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 141 | PDX | BT-28 | Medulloblastoma | 13 | Male | African-American | Brain | Diagnosis |
| 142 | PDX | BT-45 | Medulloblastoma | 9 | Male | African-American | Cerebellum | Diagnosis |
| 143 | PDX | BT-46 | Medulloblastoma | 2 | Male | Hispanic or Latino | Brain | Diagnosis |
| 144 | PDX | BT-47 | Ependymoma | 0.86 | Female | Not recorded | posterior fossa | Diagnosis |
| 145 | PDX | BT-50 | Medulloblastoma | 13y 1m | Male | White | Brain | Diagnosis |
| 146 | PDX | UTH-0462 | Primary anaplastic | 5y 11m | Female | Hispanic/ White | Posterior fossa | No treatment |
| 147 | PDX | UTH-0466 | Medulloblastoma Grade IV | 2y 6m | Female | Non-Hispanic/White | Posterior fossa with diffused metastasis in CNS&spine | No treatment |
| 148 | PDX | UTSW-0736.FT1516 | Medullaobloastoma Grade IV | Non-Hispanic/White | Posterior fossa with diffused metastasis in CNS&spine |
| Brain Tumor (CNS, Ependymoma) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 149 | PDX | BT-36 | Ependymoma | 3 | Female | White | Brain | Diagnosis |
| 150 | PDX | BT-41 | Ependymoma | 27 | Male | White | Brain | Relapse |
| 151 | PDX | BT-44 | Ependymoma anaplastic | 2 | Female | Black | Posterior fossa | Relapse |
| 152 | PDX | BT-43 | Ependymoma | 9.93 | Female | Not recorded | Posterior cranial fossa | Recurrent |
| 153 | PDX | BT-57 | Ependymoma (Focal anaplasia) | 0.81 | Male | Not recorded | Posterior cranial fossa | Recurrent |
| 154 | PDX | UTH-0587-000 | Ependymoma | Hispanic/White |
| Brain Tumor (CNS, Astrocytoma) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 155 | PDX/cell line | BT-35 | Astrocytoma | Not recorded | Not recorded | Not recorded | Thalamus | Diagnosis |
| 156 | PDX/cell line | BT-40 | Astrocytoma Anaplastic | 18 | Male | Not recorded | Brain, NOS | Diagnosis |
| 157 | CDX/cell line | AM38 | BRAF v600e mut | |||||
| 158 | CDX/cell line | DBTRG | BRAF v600e mut |
| Brain Tumor (CNS, Primitive Neuroectodermal Tumor (PNET) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 159 | PDX | BT-27 | PNET | 2.7 | Female | Not recorded | Brain, left parieto-occipital region | Diagnosis |
| PDX | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 160 | PDX | BT-29 | AT/RT | 2 | Male | White | Frontal lobe | Diagnosis |
| 161 | PDX | BT-42 | AT/RT | 2.12 | Male | Not recorded | Left thalamus | Treated |
| 162 | PDX | BT-55 | AT/RT | 0.88 | Male | Not recorded | Right Frontal Lobe | 2nd resection prior to start of therapy |
| 163 | PDX | NCH-RBD-4 | Primary | 13 | Female | Not recorded | Right Parietal Lobe | Diagnosis |
| 164 | Cell line | MP-MRT-AN | ||||||
| 165 | Cell line | KP-MRT-RY | ||||||
| 166 | Cell line | KP-MRT-NS | ||||||
| 167 | Cell line | KP-MRT-YM |
| Brain Tumor (CNS, Glioblastoma) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 168 | PDX | GBM2 | Glioblastoma | 4y 2m | Female | White | Brain NOS | Relapse |
| 169 | PDX | BT-39 | Glioblastoma | 18 | Male | Hispanic | Brain NOS | Relapse |
| 170 | PDX | BT-56 | Glioblastoma | 11 | Female | White | Brain NOS | Relapse |
| 171 | PDX | UTH-0516 | Primary | 6y 10m | Male | Hispanic/ White | Right parietal lobe | Diagnosis |
| Other Brain Tumor | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 172 | PDX | BT-53 | Primitive chordoma | 3.84 | Female | Not recorded | Brain, skull base tumor | Debulking resection - Primary resection 1 month prior. Tx history unknown |
| 173 | PDX | NCH-MN-1 | Anaplastic rhabdoid meningioma | 16 | Female | Not recorded | Left occipital mass | Diagnosis |
| 174 | PDX | NCH-PXA-1 | Pleomorphic xanthoastrocytoma (PXA) | 6 | Male | Not recorded | Brain | Recurrent |
| Osteosarcoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 175 | cell line | OS-17 * | Primary | 16y 5m | Male | White | Femur | Diagnosis |
| 176 | PDX | OS-1 | Primary | 12 | Male | African-American | Tibia | Diagnosis |
| 177 | PDX | OS-2 | Primary | 14y 7m | Female | White | Femur | Diagnosis |
| 178 | PDX | OS-9 | Primary | 11 | Male | White | Right distal femur | Diagnosis |
| 179 | PDX | OS-33 | Primary | 7 | Female | White | Right humerus | Diagnosis |
| 180 | PDX | OS-31 | Primary | 5 | Female | African-American | Right distal femur | Diagnosis |
| 181 | PDX | OS-29 | Metastasis | 18 | Male | White | Lung mass | Relapse |
| 182 | PDX | NCH-OS-1 | Primary | 24 | Male | Not recorded | Right proximal ulna | Diagnosis |
| 183 | PDX | OS-34 | Primary | 14 | Female | Not recorded | Left femur | Diagnosis |
| 184 | PDX | OS-35 | Metastasis | 20 | Male | Not recorded | Chest wall metastasis | Relapse following surgery |
| 185 | PDX | OS-36 | Metastasis | 21 | Female | White | Lung met chondroblastic | Relapse following surgery |
| 186 | PDX | OS-37 | Metastasis | 20 | Male | White | Lung met/left 7th rib (domal evolution?) | Treated |
| 187 | PDX | OS-38 | Primary | 14 | Male | African-American | Left femur | Diagnosis |
| 188 | PDX | OS-39 | Primary | 6 | Female | African-American | Left proximal humerus | Diagnosis |
| 189 | PDX | OS-39R | Primary | 8 | Female | African-American | Left distal femur High-grade | Recurrent |
| 190 | PDX | OS-40 | Primary | 19 | Male | African-American | Right tibia | Diagnosis |
| 191 | PDX | OS-41 | Primary | 13 | Male | White | Tibial mass | No treatment |
| 192 | PDX | OS-42 | Metastasis | 24 | Male | White | Lung met | Recurrent |
| 193 | PDX | OS-43 | Metastasis | 13 | Male | African-American | Black | No treatment |
| 194 | PDX | OS-44 | Primary | 17 | Female | White | Proximal tibia | Treated |
| 195 | PDX | OS-45 | Primary | 13 | Male | African-American | Left humerus | No treatment |
| 196 | PDX | OS-46 | Primary (high-grade) | 12 | Male | White | Right distal femur | Treated |
| 197 | PDX | OS-47 | Primary (high-grade) | 10 | Male | White | Left distal femur | No treatment |
| 198 | PDX | OS-48 | Metastasis | 14 | Female | White | Metastasis lung | No treatment |
| 199 | PDX | OS-49 | Primary | 8 | Female | African-American | Right humerus | Treated |
| 200 | PDX | OS-50 | Primary | 16 | Female | White | Left proximal tibia | No treatment |
| 201 | PDX | OS-52 | Primary | 14 | Female | White | Left proximal tibia | Diagnosis biopsy |
| 202 | PDX | OS-53 | Primary | 7 | Male | White | Left distal femur | Diagnosis biopsy |
| 203 | PDX | OS-54 | Primary | 14 | Female | Multiple races | Right distal femur | Diagnosis biopsy |
| 204 | PDX | OS-55 | Primary | 18 | Male | Other race | Left distal femur High-grade | Diagnosis |
| 205 | PDX | OS-56 | Primary | 14 | Female | African-American | Left humerus High-grade | Diagnosis |
| 206 | PDX | OS-58 | Metastasis | 14 | Male | African-American | Left lung met | Recurrent |
| 207 | PDX | OS-60 | Primary | 21 | Male | White | Right arm mass high-grade | Recurrent |
| 208 | PDX | UTH-0471-2 | Metastasis | 13y 4m | Male | Hispanic/White | Metastasis lung | Treated |
| 209 | PDX | UTH-0500-000 | Primary | 13y 8m | Male | Hispanic/White | Right distal femur | No treatment |
| 210 | PDX | UTSW-1922 | Primary metastasic | 7 | Male | African-American | High-grade right tibia/joint | No treatment |
| 211 | PDX | UTSW-1981 | Primary (high-grade metastatic) | 12 | Male | Non-Hispanic / Asian | Right tibia | Chemotherapy |
| 212 | PDX | UTSW-2035 | Primary | 13 | Male | Non-Hispanic / White | High-grade metastatic | Chemotherapy |
| 213 | PDX | UTH-0522-000 | Primary | 15y 11m | Male | Hispanic/White | Left femur | Diagnosis |
| 214 | PDX | UTH-0532-000 | Primary | 16y 4m | Female | Hispanic/White | Left tibia | Diagnosis |
| 215 | PDX | UTSW-1792FT2344 | Primary metastatic | 17 | Female | Hispanic/White | Lung, NOS | Chemotherapy |
| 216 | PDX | UTH-0556 | Metastasis | 18y 8m | Female | Hispanic/White | Metastatic lung | Autopsy |
| 217 | PDX | UTH-0560-000 | Metastasis | 11y 1m | Male | Non-Hispanic/White | Metastatic lung | Autopsy |
| 218 | PDX | UTH-0560-000-1 | Metastasis | 11y 1m | Male | Non-Hispanic/White | Skin-rib cage | Autopsy |
| 219 | PDX | UTH-0564-000 | Primary | 11yr1m | Male | Non-Hispanic / White | Right femur | Chemotherapy |
| 220 | PDX | UTSW-0744.FT1525 | Left lemur | |||||
| 221 | PDX | OS-43 (TPMX) | Secondary | 13 | Male | African-American | Lung metastasis | Diagnosis |
| 222 | PDX | OS-44 (KPDX-x) | Secondary osteoblastic | 8 | Male | Not recorded | Distal femur | Chemotherapy |
| 223 | PDX | OS-45 (TSX pr1) | Secondary osteoblastic | 17 | Male | Not recorded | Distal femur | Chemotherapy |
| 224 | PDX | OS-46 (AOX) | Secondary | 37 | Male | Not recorded | Distal femur | Diagnosis |
| 225 | PDX | OS-49 (STTX-sc) | Secondary fibroblastic | 40 | Male | Not recorded | Os frontalis | Chemotherapy |
| 226 | PDX | OS-51 (CHLX) | Secondary | 16 | Male | European | Distal femur | Post-treatment |
| 227 | PDX | OS-54 (OHS-x) | Primary | 16 | Male | Not recorded | Distal femur | Diagnosis |
| 228 | PDX | OS-55 (SBX) @ | Primary | 68 | Female | Other | Distal femur | Not recorded |
| 229 | PDX | OS-56 (TTX) | Primary | 40 | Male | African-American | Humerus | Diagnosis |
| 230 | PDX | OS-58 (ALSKX) @ | Secondary | 42 | Male | Not recorded | Lung | Chemotherapy |
| 231 | PDX | OS-25 @ | Not recorded | Not recorded | Not recorded | Not recorded | Not recorded | Not recorded |
| 232 | PDX | OS-32 @ | Not recorded | Not recorded | Not recorded | Not recorded | Not recorded | Not recorded |
| 233 | PDX | OS-51 | Primary | 16 | Male | White | Left distal femur | Treated |
| 234 | PDX | TB36-0041 | high grade osteosarcoma, Primary | 11 yo | Male | Left femur | Treated | |
| 235 | PDX | TB36-0012 | Metastasis | 13 yo | Female | right lung | Treated |
| Neuroblastoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 236 | PDX | NB-EBc1 | Primary | 2.6 | Male | Not recorded | Adrenal mass | Relapse |
| 237 | PDX | CHLA-79 | Primary | 2 | Female | Not recorded | Bone marrow | Relapse |
| 238 | PDX | NB-1643 | Primary | 1.7 | Male | Not recorded | Retroperitoneal | Diagnosis |
| 239 | PDX | NB-1382 | Secondary | 3.5 | Female | Not recorded | Retroperitoneal | Relapse |
| 240 | PDX | SK-N-AS | Secondary | 6 | Female | White | Bone marrow | Relapse |
| 241 | PDX | UTSW-1853 | Primary | 1 | Female | Non-Hispanic/AA | Thorax | Chemotherapy |
| 242 | PDX | UTSW-1913 | Primary | 5 | Male | Hispanic/White | Left adrenal gland | No treatment |
| 243 | PDX | UTSW-0806.FT1628 | Primary | |||||
| 244 | PDX | UTSW-0512.FT0963 | Primary | 1 | Male | Non-Hispanic/White | Left posterior mediastinum | No treatment |
| 245 | PDX | UHS-0530 | Primary metastatic | 2y 6m | Male | Non-Hispanic/White | Left calvarial lesion | Diagnosis |
| 246 | PDX | NB-SD | Primary | 1 | Male | Not recorded | Bone marrow | Relapse |
| 247 | PDX | NB-1771 | Primary | 2.1 | Male | Not recorded | Adrenal mass | Diagnosis |
| 248 | PDX | NB-1691 | Primary | 1.9 | Male | Not recorded | Retroperitoneal | Relapse |
| Germ Cell Tumor (+mixed) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 249 | PDX | UTSW-1917 | Mixed GCT | 17 | Male | Hispanic/White | Right testicle | No treatment |
| 250 | PDX | UTSW-1979 | Mixed malignant GCT | 15 | Male | Hispanic/White | Left testicle | Chemotherapy |
| 251 | PDX | UTSW-2129 | GCT | 11 | Female | Non-Hispanic/Other | Left ovary | No treatment |
| 252 | PDX | UTSW-1795 | Testicular tumor (GCT) | 18 | Male | Hispanic | Right testicle | No treatment |
| 253 | PDX | COG-883129 | GCT | 11 | Female | Not reported | Ovary yolk sack | Diagnosis |
| 254 | PDX | COG-892257 | GCT | 10 | Female | African-American | Ovary – non seminnomatous | Diagnosis |
| 255 | PDX | COG-896751@ | GCT | Male | Right testicle | |||
| 256 | PDX | COG933694 | GCT | 18 | Metastatic site, upper lobe, lung. Primary site - anterior mediastinum. | Chemotherapy | ||
| 257 | PDX | COG937464 | GCT | 18 | Primary site - testis, metastaticsite - retroperitoneum. Specimen tissue site - pelvic cavity | Chemotherapy | ||
| 258 | PDX | COG-907244 | Mixed GCT | Not available | ||||
| 259 | PDX | UTSW-1826 | Testicular tumor (GCT) | 15 | Male | Hispanic/White | Left testicle | No treatment |
| Alveolar Soft Part Sarcoma (ASPS) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 260 | PDX | ASPS-KY | Metastasis | 27 | Female | Asian | Lung | Recurrent |
| 261 | PDX | NCI-ASPS | Metastasis | 39 | Female | Not recorded | Lymph node | Recurrent |
| Clear Cell Sarcoma (CCS) (ASPS) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 262 | PDX | UTSW-1754 | Primary | 1 | Male | Non-Hispanic/White | Kidney | No treatment |
| 263 | PDX | UTSW-0529.FT1214 | Primary | 13 | Female | African-American | Right tibia | Treated (RT) |
| 264 | PDX | UTSW_FT2324 | Primary | 16m | Male | Hispanic/White | Left kidney | Chemotherapy |
| 265 | PDX | NCH-CCS-1 | Metastasis | 14 | Female | White | Lymph node | Recurrent |
| Small Cell Carcinoma (CCS) (ASPS) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 266 | PDX | NCH-CA-1 | Primary | 7 | Female | Not recorded | Abdominal mass | Diagnosis |
| 267 | PDX | NCH-CA-2 | Large cell variant (ovarian Ca) | 7 | Female | Not recorded | Paracaval lymph node | Treated |
| 268 | PDX | NCH-CA-3 | Non-malignant lesion | 4 | Male | Not recorded | Transverse Colon | Diagnosis |
| Synovial Sarcoma (ASPS) | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 269 | PDX | UTH-0590-000 | Synoival sarcoma of gluteous | Hispanic/White | ||||
| 270 | CDX | Aska-SS | Cells form Riken Cell Bank | |||||
| 271 | CDX | Yamato-SS | Cells form Riken Cell Bank | |||||
| 272 | CDX | HS-SY-II | Cells form Riken Cell Bank | |||||
| MPNST | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 273 | CDX/cell line | S462 | Cells from Tim Cripe/NCH | |||||
| 274 | CDX/cell line | T265 | Cells from Tim Cripe/NCH | |||||
| 275 | CDX/cell line | STS-26T | Cells from Tim Cripe/NCH |
| Other Sarcoma | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 276 | PDX | COG-895452 | Ovarian | 12y | Female | African-American | Ovary - teratoma | Diagnosis |
| 277 | PDX | UTH-0533 | Adenocarcinoma | 6y 10m | Male | Hispanic/White | Parotid gland | Recurrent |
| 278 | PDX | UTSW-1982 | Malignant epitheloid mesothelioma primary | 16 | Male | Hispanic/White | Abdomen | No treatment |
| 279 | PDX | UTSW-1939 (CHD-875194) | Adrenal cortical carcinoma | 13 | Male | Non-Hispanic/White | Left Adrenal gland | No treatment |
| 280 | PDX | UTSW-1796 | Leydig cell tumor of ovary | 16 | Female | AA /White | Right Ovary | No treatment |
| 281 | PDX | UTSW-1907 | Sarcoma of brain | Non-Hispanic/White | ||||
| 282 | PDX | COG-900533 | Ovarian cancer | Not available | ||||
| 283 | PDX | COG-900797 | Ovarian cancer | Not available | ||||
| 284 | PDX | 0565-000 | Lymphoma | |||||
| 285 | PDX | UTSW-1907 | High-grade Pleiomorphic | 5 | Female | Non-Hispanic/White | Lung | Chemotherapy |
| ALL | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 286 | PDX | MCH-0030 | Not recorded | 13y 5m | Female | Non-White/Non-Hispanic | Blood | Diagnosis |
| 287 | PDX | MCH-0031 | Not recorded | 7m | Female | Hispanic | Blood | Diagnosis |
| 288 | PDX | UTSW-0100 | Primary | 14y | Male | Hispanic | Bone marrow | No treatment |
| 289 | PDX | MCH-0037 | Not recorded | 20y 8m | Female | Hispanic | Bone marrow | Relapsed |
| 290 | PDX | UHS-0528 | Not recorded | 22y | Male | Hispanic | Blood | Multiple relapses |
| 291 | PDX | UTSW-093 | Primary | 14y | Male | White | Bone marrow | No treatment |
| 292 | PDX | MCH-0450 | Down syndrome | 27y 3m | Female | Hispanic | Bone marrow | Relapsed |
| 293 | PDX | UHS-0457 | Primary | 6y 10m | Male | Hispanic/White | Bone marrow | Diagnosis |
| 294 | PDX | UTSW-0766.BM1567 | Primary | 4y | Female | Hispanic/White | Bone marrow | Diagnosis |
| 295 | PDX | UHS-0645 | Primary | 12y | Female | non-Hispanic | Bone marrow | Diagnosis |
| 296 | PDX | UHS-0514-000 | Recurrent | 24y | Male | Hispanic | Bone marrow | Relapsed |
| Pre-B ALL PDX | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 297 | PDX | UHS-0448 | Primary | 13y 5m | Male | White/Hispanic | Bone marrow | Diagnosis |
| 298 | PDX | UHS-0453 | Primary | 16y 3m | Male | White/Hispanic | Bone marrow | Diagnosis |
| 299 | PDX | UHS-0485 | Primary | 25y 4m | Female | White/Hispanic | Blood | 2nd relapse |
| 300 | PDX | UHS-0487 | Recurrent | 7y 2m | Female | White/Hispanic | Blood | Relapsed |
| 301 | PDX | MCH-0026 | Not recorded | 2y | Male | White/Hispanic | Blood | Diagnosis |
| 302 | PDX | UHS-0495 | Primary | 19y 8m | Male | White/Hispanic | Bone marrow | Diagnosis |
| 303 | PDX | UTSW-1873 | Primary | 4y | Female | White | Bone marrow | No treatment |
| 304 | PDX | UTSW-0286-BM0122 | Primary | 2y | Male | White | Bone marrow | No treatment |
| 305 | PDX | UTSW-0289-BM0135 | Primary | 4y | Female | Hispanic | Bone marrow | No treatment |
| 306 | PDX | UTSW-0393.BM0661 | Primary | 4y | Male | Hispanic | Bone marrow | Chemotherapy |
| 307 | PDX | UTSW-0429.BM0678 | Primary | 7y | Male | Non- | Bone marrow | No treatment |
| 308 | PDX | UTSW-0457.Le0776 | With t(1:22) and t(12:21) | 4y | Female | Asian | Blood | No treatment |
| 309 | PDX | UHS-0529 | Primary | 19y 3m | Male | Hispanic | Blood | Diagnosis |
| 310 | PDX | UHS-0534 | Primary | 3y 11m | Male | Hispanic/White | Blood | Diagnosis |
| 311 | PDX | UHS-0485R | Recurrent | 25y | Female | Hispanic/White | Bone marrow | Relapsed |
| 312 | PDX | UTSW-0684.Le1396 | Primary | 17y | Female | non-Hispanic/White | Bone marrow | No treatment |
| 313 | PDX | MCH-0040 | Primary | 6y | Female | non-Hispanic | Blood | Diagnosis |
| 314 | PDX | UTSW-0734-BM1512 | Primary | 20m | Female | Hispanic/White | Bone marrow | Diagnosis |
| 315 | PDX | UTSW-0737-Le1513 | Primary | 40 days | Male | non-Hispanic/White | Bone marrow | Diagnosis |
| 316 | PDX | UTSW-0814-BM1632 | Primary | 6y 10m | Male | non-Hispanic/White | Bone marrow | Diagnosis |
| 317 | PDX | UHS-0618 | Primary | 10y 5m | Female | non-Hispanic | Bone marrow | Diagnosis |
| 318 | PDX | UTSW-0277.BM1726 | Bone marrow | |||||
| 319 | PDX | UTSW-0814-BM1741 | Primary | 6y | Female | non-Hispanic/White | Bone marrow | Diagnosis |
| 320 | PDX | UTSW-0929-BM1810 | Primary | 15y 11m | Male | Hispanic | Bone marrow | Diagnosis |
| 321 | PDX | Pilot 0677-000 | Primary | Bone marrow+Blood | Diagnosis | |||
| 322 | PDX | Pilot 0703-000 | Primary | 20y 8m | Male | Hispanic | Blood | Diagnosis |
| 323 | PDX | Pilot 0706-000 | Primary | 14y | Blood | Diagnosis | ||
| 324 | PDX | UTSW-0318-BM0349 | Primary | 3y | Male | Hispanic | Bone marrow | Treated |
| T-cell ALL | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 325 | PDX | MCH-0036 | Primary | 4y 7m | Male | Hispanic | Blood | Diagnosis |
| 326 | PDX | UTSW-2042 | Primary | 10y | Male | Hispanic | Bone marrow | Chemotherapy |
| 327 | PDX | UTSW-1947 | With hyperleukocytosis | 10y | Male | Hispanic | Blood | No treatment |
| 328 | PDX | UTSW-0461. LE0797 | Primary | 11y | Female | Hispanic | Blood | No treatment |
| 329 | PDX | UHS-565 | Primary | 15y 11m | Male | Non-Hispanic/White | Mediastinum | No treatment |
| 330 | PDX | UTSW-0734-BW1601 | Primary | 14y | Male | Non-Hispanic/White | Blood | Diagnosis |
| 331 | PDX | Pilot 0633-000 | Primary | 12.5y | Male | Blood |
| B-cell ALL | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 332 | PDX | MCH-0033 | N/A | 8y | Male | Hispanic | Bone marrow | Diagnosis |
| 333 | PDX | MCH-0035 | N/A | 15y | Male | Hispanic | Blood | Diagnosis |
| 334 | PDX | UHS-0518 | Primary | 7y 11m | Male | African American | Bone marrow | Diagnosis |
| 335 | PDX | UHS-0557 | Primary | 7y 2m | Female | Hispanic/White | Blood | Diagnosis |
| 336 | PDX | UHS-0574 | Primary | 2y | Female | Hispanic | Blood | Diagnosis |
| 337 | PDX | UHS-0574R | Recurrent | 4y | Female | Hispanic | Blood+BM | Relapsed |
| 338 | PDX | UHS-0592 | Primary | 2y | Male | Hispanic | Blood | Diagnosis |
| 339 | PDX | UHS-0593 | Primary | 21y | Female | Hispanic | Bone marrow | Diagnosis |
| 340 | PDX | UHS-0604 | Primary | 9y | Male | Hispanic | Blood | Diagnosis |
| 341 | PDX | UHS-0612 | Primary | 19y | Female | Hispanic | Blood | Diagnosis |
| 342 | PDX | UHS-0627 | Primary | 2y9m | Female | Hispanic | Blood | Diagnosis |
| 343 | PDX | Pilot 0621-000 | Recurrent | 24y | Female | Blood | Relapsed | |
| 344 | PDX | UHS-0501 | Primary, high risk | 2y | Male | Hispanic | Bone marrow | Diagnosis |
| AML | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 345 | PDX | UTSW-0554.BM1054 | Primary | 13 | Male | non-Hispanic/Asian | Bone marrow | No treatment |
| 346 | PDX | UTSW-0554.BM1643 | Primary | 9m | Male | Non-Hispanic/White | Bone marrow | Relapsed |
| 347 | PDX | UTSW-0882. LE1738 | Recurrent | 5y | Male | Hispanic/White | Leukapheresis | Relapsed |
| 348 | PDX | Pilot 0671-000 | Primary | 15y | Male | Blood | Diagnosis |
| Other ALL PDX | ||||||||
|---|---|---|---|---|---|---|---|---|
| # | PDX/CDX/Cell line | Model ID | Subclass | Age, years old | Gender | Race | Site | Diagnosis or Relapse |
| 349 | PDX | UTSW-0392.LE0543 | Mixed phenotype acute leukemia, MPAL | 8m | Female | White | Blood | No treatment |
# Cell lines and CDXs
* PDX, also available as cell line
@ In process of acquiring demographics data
N/A, not available at the time of table preparation
